Healthcare ETF ASX | Health Sector ETF | BetaShares
  • Request info pack
  • Download Factsheet
  • Request a call
  • Request Lonsec research
  • View all funds
  • Download Factsheet

Thank you for your request, an email will be sent to you shortly. If you don’t receive it within 30 minutes please contact info@betashares.com.au

OVERVIEW

Fund Objective

DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Benefits of DRUG

Healthcare – a global growth opportunity

Ageing populations, rising living standards and ongoing medical advancements are expected to support increasing ongoing demand for healthcare products and services.

Simple access to global healthcare giants

Access a diversified portfolio of the world’s leading healthcare companies, such as Johnson & Johnson, Pfizer and Roche, in one trade.

Cost-effective

Passive, index-tracking approach means no ‘active manager’ fees, making DRUG a cost-effective investment for those seeking exposure to the global healthcare sector.

How to invest

  • You can buy or sell units just like you’d buy or sell any share on the ASX.
  • Fund requires no minimum investment.

KEY FACTS

Pricing Information 27 July 2021

Current Price
Last Trade* -
% Change (prev day) -
Bid (delayed) -
Offer (delayed) -
* Data is delayed by at least 20 minutes.
Download NAV history
NAV
NAV/Unit* $7.65
* As at 23 July 2021

Profile

Net Assets* ($A) $121,525,649
Units Outstanding* (#) 15,880,459
Mgmt Costs** (% p.a.) 0.57%
Distribution Frequency Semi-annual
Distribution Reinvestment Plan (DRP) Full or partial participation available
Issuer BetaShares Capital Ltd
Fund Administrator RBC Investor Services
Custodian RBC Investor Services
Registry Link Market Services
Auditor KPMG
* As at 23 July 2021
**Certain additional costs apply. Please refer to PDS.

Trading Information

ASX Code DRUG
Bloomberg Code DRUG AU
IRESS Code DRUG.AXW
Trading Hours 10.00-16.00 (AEST)
iNAV IRESS Code N/A

Index Information

Index Nasdaq Global ex-Australia Healthcare Hedged AUD Index
Index Provider Nasdaq
Index Ticker N/A
Bloomberg Index Ticker NQXAUHHN Index
Index Methodology

Portfolio Holdings

Name Weight (%)
JOHNSON & JOHNSON 7.6
UNITEDHEALTH GROUP INC 6.5
ROCHE HOLDING AG 4.6
PFIZER INC 4.1
NOVARTIS AG 4.0
ABBOTT LABORATORIES 3.7
ABBVIE INC 3.6
THERMO FISHER SCIENTIFIC INC 3.5
ELI LILLY & CO 3.4
MERCK & CO INC 3.3
Ticker Name Weight (%) Asset Class Sector Country Currency Shares/Unit (#) Market Value (AUD) Notional Value (AUD)
JNJ UN JOHNSON & JOHNSON 7.6 Equities Healthcare United States USD 40,236 $9,383,848 $9,383,848
UNH UN UNITEDHEALTH GROUP INC 6.5 Equities Healthcare United States USD 14,219 $8,063,096 $8,063,096
ROG SE ROCHE HOLDING AG 4.6 Equities Healthcare Switzerland CHF 11,017 $5,648,367 $5,648,367
PFE UN PFIZER INC 4.1 Equities Healthcare United States USD 88,783 $5,023,724 $5,023,724
NOVN SE NOVARTIS AG 4.0 Equities Healthcare Switzerland CHF 39,129 $4,885,060 $4,885,060
ABT UN ABBOTT LABORATORIES 3.7 Equities Healthcare United States USD 28,181 $4,621,592 $4,621,592
ABBV UN ABBVIE INC 3.6 Equities Healthcare United States USD 28,013 $4,494,782 $4,494,782
TMO UN THERMO FISHER SCIENTIFIC INC 3.5 Equities Healthcare United States USD 5,922 $4,279,180 $4,279,180
LLY UN ELI LILLY & CO 3.4 Equities Healthcare United States USD 12,625 $4,184,624 $4,184,624
MRK UN MERCK & CO INC 3.3 Equities Healthcare United States USD 38,151 $4,016,058 $4,016,058
DHR UN DANAHER CORP 3.2 Equities Healthcare United States USD 10,069 $3,981,534 $3,981,534
MDT UN MEDTRONIC PLC 2.9 Equities Healthcare United States USD 20,312 $3,544,535 $3,544,535
BMY UN BRISTOL-MYERS SQUIBB CO 2.7 Equities Healthcare United States USD 35,413 $3,285,534 $3,285,534
NOVOB DC NOVO NORDISK A/S 2.6 Equities Healthcare Denmark DKK 26,145 $3,208,000 $3,208,000
AZN LN ASTRAZENECA PLC 2.5 Equities Healthcare Britain GBP 19,155 $3,033,832 $3,033,832
AMGN UW AMGEN INC 2.2 Equities Healthcare United States USD 8,111 $2,727,745 $2,727,745
MRNA UW MODERNA INC 2.1 Equities Healthcare United States USD 5,350 $2,533,587 $2,533,587
SAN FP SANOFI 1.9 Equities Healthcare France EUR 16,797 $2,364,629 $2,364,629
ISRG UW INTUITIVE SURGICAL INC 1.9 Equities Healthcare United States USD 1,728 $2,290,691 $2,290,691
ZTS UN ZOETIS INC 1.7 Equities Healthcare United States USD 7,530 $2,081,228 $2,081,228
GSK LN GLAXOSMITHKLINE PLC 1.6 Equities Healthcare Britain GBP 74,215 $1,962,766 $1,962,766
ANTM UN ANTHEM INC 1.5 Equities Healthcare United States USD 3,689 $1,914,564 $1,914,564
SYK UN STRYKER CORP 1.5 Equities Healthcare United States USD 5,199 $1,853,952 $1,853,952
CI UN CIGNA CORP 1.3 Equities Healthcare United States USD 5,007 $1,582,990 $1,582,990
BDX UN BECTON DICKINSON AND CO 1.3 Equities Healthcare United States USD 4,612 $1,572,062 $1,572,062
GILD UW GILEAD SCIENCES INC 1.3 Equities Healthcare United States USD 16,709 $1,565,646 $1,565,646
EW UN EDWARDS LIFESCIENCES CORP 1.1 Equities Healthcare United States USD 9,366 $1,391,040 $1,391,040
HCA UN HCA HEALTHCARE INC 1.0 Equities Healthcare United States USD 3,828 $1,291,209 $1,291,209
BSX UN BOSTON SCIENTIFIC CORP 1.0 Equities Healthcare United States USD 21,409 $1,282,331 $1,282,331
ILMN UW ILLUMINA INC 1.0 Equities Healthcare United States USD 1,852 $1,245,838 $1,245,838
LONN SE LONZA GROUP AG 1.0 Equities Healthcare Switzerland CHF 1,182 $1,231,206 $1,231,206
BAYN GY BAYER AG 1.0 Equities Healthcare Germany EUR 14,647 $1,198,731 $1,198,731
IDXX UW IDEXX LABORATORIES INC 1.0 Equities Healthcare United States USD 1,271 $1,197,045 $1,197,045
EL FP ESSILORLUXOTTICA SA 1.0 Equities Consumer Discretionary France EUR 4,735 $1,174,062 $1,174,062
2269 HK WUXI BIOLOGICS CAYMAN INC 0.9 Equities Healthcare China HKD 50,500 $1,144,398 $1,144,398
4502 JT TAKEDA PHARMACEUTICAL CO LTD 0.9 Equities Healthcare Japan JPY 25,000 $1,139,001 $1,139,001
HUM UN HUMANA INC 0.9 Equities Healthcare United States USD 1,759 $1,125,273 $1,125,273
REGN UW REGENERON PHARMACEUTICALS INC 0.8 Equities Healthcare United States USD 1,295 $1,030,849 $1,030,849
IQV UN IQVIA HOLDINGS INC 0.8 Equities Healthcare United States USD 3,040 $1,027,971 $1,027,971
7741 JT HOYA CORP 0.8 Equities Healthcare Japan JPY 5,600 $1,014,012 $1,014,012
VRTX UW VERTEX PHARMACEUTICALS INC 0.8 Equities Healthcare United States USD 3,572 $972,286 $972,286
ALGN UW ALIGN TECHNOLOGY INC 0.8 Equities Healthcare United States USD 1,118 $968,771 $968,771
VEEV UN VEEVA SYSTEMS INC 0.7 Equities Healthcare United States USD 2,014 $910,647 $910,647
PHIA NA KONINKLIJKE PHILIPS NV 0.7 Equities Healthcare Netherlands EUR 13,727 $894,471 $894,471
BIIB UW BIOGEN INC 0.7 Equities Healthcare United States USD 1,982 $875,567 $875,567
A UN AGILENT TECHNOLOGIES INC 0.7 Equities Healthcare United States USD 4,204 $869,279 $869,279
CNC UN CENTENE CORP 0.7 Equities Healthcare United States USD 8,687 $866,341 $866,341
DXCM UW DEXCOM INC 0.7 Equities Healthcare United States USD 1,365 $853,764 $853,764
BAX UN BAXTER INTERNATIONAL INC 0.7 Equities Healthcare United States USD 7,577 $834,643 $834,643
ALC SE ALCON INC 0.6 Equities Healthcare Switzerland CHF 7,926 $765,455 $765,455
4568 JT DAIICHI SANKYO CO LTD 0.6 Equities Healthcare Japan JPY 27,500 $751,572 $751,572
4519 JT CHUGAI PHARMACEUTICAL CO LTD 0.4 Equities Healthcare Japan JPY 10,700 $542,286 $542,286
2413 JT M3 INC 0.4 Equities Healthcare Japan JPY 5,600 $510,341 $510,341
068270 KP CELLTRION INC 0.4 Equities Healthcare South Korea KRW 1,421 $450,157 $450,157
TDOC UN TELADOC HEALTH INC 0.3 Equities Healthcare United States USD 2,083 $428,675 $428,675
DIM FP SARTORIUS STEDIM BIOTECH 0.2 Equities Healthcare France EUR 380 $280,566 $280,566
207940 KP SAMSUNG BIOLOGICS CO LTD 0.2 Equities Healthcare South Korea KRW 262 $276,044 $276,044
241 HK ALIBABA HEALTH INFORMATION TEC 0.1 Equities Healthcare China HKD 64,000 $156,998 $156,998
OGN UN ORGANON & CO 0.1 Equities Healthcare United States USD 3,812 $154,219 $154,219
3692 HK HANSOH PHARMACEUTICAL GROUP CO 0.1 Equities Healthcare China HKD 16,000 $81,490 $81,490
AUD AUD - AUSTRALIA DOLLAR FX Forwards AUD 117,320,073
CHF CHF - SWISS FRANC FX Forwards CHF -8,411,990
DKK DKK - DANISH KRONE FX Forwards DKK -13,779,794
EUR EUR - EURO FX Forwards EUR -3,674,539
GBP GBP - BRITISH POUND FX Forwards GBP -2,722,024
HKD HKD - HONG KONG DOLLAR FX Forwards HKD -8,804,387
JPY JPY - JAPANESE YEN FX Forwards JPY -333,759,049
KRW KRW - KOREAN WON FX Forwards KRW -605,346,508
USD USD - UNITED STATES DOLLAR FX Forwards USD -63,715,688
Download CSV
* As at 23 July 2021. Excludes cash

Sector Allocation

Pharmaceuticals
43.5%
Health Care Equipment
19.6%
Biotechnology
11.5%
Managed Health Care
9.8%
Life Sciences Tools & Services
8.4%
Health Care Supplies
2.3%
Health Care Technology
1.7%
Health Care Services
1.4%
Apparel, Accessories & Luxury
1.0%
Other
0.9%
* As of 30 June 2021

Country Allocation

United States
72.4%
Switzerland
10.4%
Britain
4.3%
Japan
3.4%
France
3.2%
Denmark
2.5%
China
1.3%
Germany
1.0%
Netherlands
0.8%
South Korea
0.6%
* As of 30 June 2021

PERFORMANCE

Fund Returns After Fees (%)

  Fund Index
1 month 3.71% 3.80%
3 months 8.86% 9.01%
6 months 11.16% 11.37%
1 year 19.40% 19.82%
3 year p.a 13.19% 13.50%
5 year p.a - 11.27%
Since inception (p.a) 10.39% 10.72%
Inception date 4-Aug-16 -
* As at 30 June 2021

Chart

Chart Type
Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.

DISTRIBUTIONS

Yield Information

Distribution Frequency Semi-Annual
12 Mth Distribution Yield* (%) 0.8%
12 Mth Gross Distribution Yield* (%) -
Franking Level -
*As at 30 June 2021. Yield figures are calculated by summing the prior 12 month net and gross fund per unit distributions divided by the fund closing NAV per unit. Past performance is not an indicator of future performance.

Recent Distributions

Ex Date Record Date Payment Date Distribution Unit ($) Annual Distribution Return (%) (1)
1-Jul-21 2-Jul-21 16-Jul-21 $0.34984 5.55%
4-Jan-21 5-Jan-21 19-Jan-21 $0.0166 1.00%
1-Jul-20 2-Jul-20 16-Jul-20 $0.04292 1.13%
2-Jan-20 3-Jan-20 17-Jan-20 $0.02494 0.46%
2-Jan-19 3-Jan-19 17-Jan-19 $0.01869 3.70%
2-Jul-18 3-Jul-18 17-Jul-18 $0.18445 3.77%
2-Jan-18 3-Jan-18 17-Jan-18 $0.01646 0.35%
View more
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. It is calculated as the difference between total Fund return and NAV return. NAV return is the change in the Fund's NAV price. Total return is the NAV return plus reinvestment of all distributions back to the Fund. Past performance not indicative of future performance.

ANNOUNCEMENTS

ASX Announcements: DRUG

Download
Showing - of

RESOURCES

Factsheet - DRUG
Download
Fund Flyer - DRUG
Download
Portfolio Holdings
Download
Product Disclosure Statement - Global Sector Series
Download
Product Disclosure Statement Update - 8 March 2021
Download
Interim Financial Report - December 2020
Download
Annual Report - June 2020
Download
NRWT and Fund Payment Notice information - June 2021 distributions
Download
NRWT and Fund Payment Notice information - December 2020 distributions
Download
View more

LEARN MORE ABOUT DRUG

Request an info pack